- Home
- / Medexus Pharma
Medexus Pharma
Stock Price
$2.6
2024-10-29
Market Capitalization
$63.3 M
2024-10-29
Revenue
$108.3 M
FY, 2025
Medexus Pharma Summary
Company Summary
- Overview
- Medexus Pharma is a pharmaceutical company. It has expertise in the therapeutic areas of rheumatology, auto-immune disease, specialty oncology, allergy, and pediatric diseases.
- Type
- Public
- Status
- Active
- Founded
- 2013
- HQ
- Chicago, IL, US | view all locations
- Website
- https://www.medexus.com
- Cybersecurity rating
- Sectors
Table of Contents
LocationsView all
2 locations detected
Chicago, IL HQ
United States
29 N Upper Wacker Dr #704
Bolton, ON
Canada
35 Nixon Rd Unit 1
Medexus Pharma Financials
Summary Financials
- Revenue (Q3, 2026)
- $25.3M
- Gross profit (Q3, 2026)
- $15.9M
- Net income (Q3, 2026)
- $80.0K
- Cash (Q3, 2026)
- $15.0M
- EBIT (Q3, 2026)
- $1.7M
- Enterprise value
- $73.7M
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026